期刊文献+

膀胱癌尿蛋白表达的研究进展

Research progress on expression of urinary proteins in carcinoma of the bladder
下载PDF
导出
摘要 膀胱癌是泌尿系统最常见的一种恶性肿瘤,分为肌层浸润性膀胱癌和非肌层浸润性膀胱癌,两者的治疗、预后有明显的不同。如何在早期区分两者对膀胱癌的治疗有很大的帮助。目前,膀胱癌的诊断以及复发的检测主要是靠膀胱镜和尿细胞学检查,以及CT、MRI等,但膀胱镜为有创性检查且费用昂贵,而尿细胞学检查敏感度很低,所以寻找一种无创可靠的标记物能快速准确地区分浸润性与非浸润性膀胱对临床治疗显得尤为重要。 The treatment and prognosis of muscle-invasive bladder cancer is different from non- muscle invasive bladder cancer. Urine cytology, cystoscopy, CT and MRI scans are commonly used for differential diagnosis of muscle-invasive and non-muscle invasive bladder cancers, but more sensitive, less expensive, non-invasive and more accurate method for diagnosis of bladder cancer need to be developed. This article reviews the expression of urinary proteins in the bladder cancer and their potential use as tumor markers in distinguishing invasive and non-invasive bladder cancers.
出处 《同济大学学报(医学版)》 CAS 2013年第2期115-119,共5页 Journal of Tongji University(Medical Science)
基金 国家自然科学基金(81001134)
关键词 浸润性膀胱肿瘤 非浸润性膀胱肿瘤 尿蛋白 muscle invasive bladder cancer non-muscle invasive bladder cancer urinary protein
  • 相关文献

参考文献29

  • 1Senga Y, Kimura G, Hattori T, et al. Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1 ) in serum and urine of patients with bladder cancer[ J ]. Urology, 1996, 48 ( 5 ) : 703 -710.
  • 2Melissourgos ND, Kastrinakis NG, Skolarikos A, et al. Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladder [J]. Urology, 2005,66(3): 536-541.
  • 3Eissa S, Kenawy G, Swellam M, et al. Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma [J]. Clin Biochem, 2004,37(9) : 803 - 810.
  • 4van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review [J]. Eur Urol, 2005, 47 (6) : 736 -748.
  • 5Hakenberg OW, Fuessel S, Richter K, et al. Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma [J]. Urology, 2004,64(6) : 1121 - 1126.
  • 6Sharpless NE, Depinho RA. Telomeres, stem cells, senescence, and cancer [J]. J Clin Invest, 2004,113(2) : 160 - 168.
  • 7Eissa S, Labib RA, Mourad MS, et al. Comparison of telomerase activity and matrix metallo-proteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer [ J ]. Eur Urol, 2003,44(6) : 687-694.
  • 8Dettlaff-Pokora A, Matuszewski M, Schlichtholz B. Telomerase activity in urine sedi-ments as a tool for noninvasive detection of bladder cancer [J].Cancer Lett, 2005,222(1) : 83 -88.
  • 9Tammi RH, Kultti A, Kosma VM, et al. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyal-uronan [J]. Semin Cancer Biol, 2008,18(4) : 288 -295.
  • 10Eissa S, Kassim SK, Labib RA, et al. Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs [J ]. Cancer, 2005,103(7) : 1356 - 1362.

二级参考文献8

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部